Groundbreaking Drug Development Technology: Frost & Sullivan Award Goes to Imperacer
Published: Oct 30, 2008
DORTMUND, Germany--(BUSINESS WIRE)--The 2008 European Immunoassay Frost & Sullivan Excellence in Technology Award has been awarded to Chimera Biotec, a bioanalytical company based in Dortmund, Germany. Chimera Biotec is recognized for its pioneering Imperacer® ultra-sensitive immunoassay system, which has a 1000-fold better sensitivity compared to ELISA (Enzyme-linked Immunosorbent Assay). With a unique value proposition in the drug development and diagnostic markets, Chimera's innovative Imperacer® products and services have experience widespread market acceptance.